| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/27/2008 | CN100370992C Doxycycline hydrochloride freeze-dried power preparation for injection, and process for preparing same |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370976C Medicine containing shikonin compound as active component |
| 02/27/2008 | CN100370965C Cleansing composition containing antifungal agent and antibacterial agent |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335772 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 02/26/2008 | US7335765 Nucleoside and oligonucleotide analogues |
| 02/26/2008 | US7335754 Ehrlichia canis genes and vaccines |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | US7335727 fusion inhibitor; high stability and high valence; higher efficacy, and lower administration dosage, and thereby lower toxicity. |
| 02/26/2008 | US7335726 antibiotic daptomycin stereoisomeric compounds; expected to be useful to treat not only "natural" pathogens, but also intermediate drug resistant and drug resistant pathogens |
| 02/26/2008 | US7335725 Lipopeptides as antibacterial agents |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335499 tRNA synthetase |
| 02/26/2008 | US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits |
| 02/26/2008 | US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus |
| 02/26/2008 | US7335365 HIV-encoded chemoattractant |
| 02/26/2008 | US7335355 Antimicrobial agent |
| 02/26/2008 | US7335353 Porcine cells comprising an adenovirus E3 gene region |
| 02/26/2008 | US7335350 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide; preventing autoimmune and inflammatory diseases and bacterial and viral infections |
| 02/26/2008 | CA2230159C Use of aminoadamantane compounds as immunoregulators |
| 02/26/2008 | CA2078544C Method and compositions for treating injury |
| 02/21/2008 | WO2008022286A2 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 02/21/2008 | WO2008022186A2 Antimicrobial sanitizing formulations with skin protection properties |
| 02/21/2008 | WO2008021956A2 Acylaminoheteroaryl hepatitis c virus protease inhibitors |
| 02/21/2008 | WO2008021936A2 Hepatitis c virus inhibitors |
| 02/21/2008 | WO2008021928A2 Hepatitis c virus inhibitors |
| 02/21/2008 | WO2008021927A2 Hepatitis c virus inhibitors |
| 02/21/2008 | WO2008021871A2 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2008021728A2 Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents |
| 02/21/2008 | WO2008021378A1 Use of adsborbent carbon microspheres to treat intestinal bacterial infections |
| 02/21/2008 | WO2008020656A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020560A1 Antibacterial agent and therapeutic agent for johne's disease comprising the same |
| 02/21/2008 | WO2008020532A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 02/21/2008 | WO2008020243A1 Treatment of dna viral infections of the eye |
| 02/21/2008 | WO2008020222A1 Pyrrole derivatives with antibacterial activity |
| 02/21/2008 | WO2008020085A2 Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy |
| 02/21/2008 | WO2008019968A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | WO2008019869A1 Medicament, use of a photo-reactive active ingredient for the production of a medicament, and treatment instrument for the treatment of superficial microbial, bacterial and viral disorders using this medicament |
| 02/21/2008 | WO2008019823A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
| 02/21/2008 | WO2008000881B1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 02/21/2008 | WO2007127012B1 Antifungal agents |
| 02/21/2008 | WO2007079312A3 Compositions and methods for treating actin-mediated medical conditions |
| 02/21/2008 | WO2007075092A8 New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs |
| 02/21/2008 | WO2007068934A3 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 02/21/2008 | WO2007027560A8 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 02/21/2008 | WO2007014238A8 Single dose use of cd20-specific binding molecules |
| 02/21/2008 | WO2006136084A8 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 02/21/2008 | WO2006053439A9 Hcv f protein and uses thereof |
| 02/21/2008 | US20080045721 Thiazole-oxime chemical intermediates to cephalosporin-linked vancomycin derivatives which have use against antibiotic-resistant bacteria including methicillin-resistant Staphylococci aureus (MRSA) |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | US20080045563 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 02/21/2008 | US20080045557 Compounds and methods to inhibit or augment an inflammatory response |
| 02/21/2008 | US20080045538 Nitro and amino substituted topoisomerase agents |
| 02/21/2008 | US20080045530 Organic Compounds and Their Uses |
| 02/21/2008 | US20080045523 Synthesis of Polyoxygenated Nitrogen Systems, Comprising Reactions Between Enamines of 1,3-Dioxan-5-Ones and Nitroolefins |
| 02/21/2008 | US20080045520 Substituted Pyrrolidine Derivative |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | US20080045511 3-chloro-5-[6-chloro-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)-phenoxy]-benzonitrile; inhibit HIV reverse transcriptase and are useful for treating Human Immunodeficiency Virus (HIV) mediated diseases |
| 02/21/2008 | US20080045509 Substituted benzyl amine compounds |
| 02/21/2008 | US20080045508 Substituted aminomethyl benzamide compounds |
| 02/21/2008 | US20080045507 Substituted benzamide modulators of the histamine h3 receptor |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045498 Polycyclic viral inhibitors |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045482 Compositions and methods for the treatment of viral infections |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080045472 Targets for human micro rnas in avian influenza virus (h5n1) genome |
| 02/21/2008 | US20080045468 Antimicrobial 2-deoxystreptamine compounds |
| 02/21/2008 | US20080045465 Phosphole Derivatives Complexed with Metals, and Pharmaceutical Uses Thereof |
| 02/21/2008 | US20080044806 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads |
| 02/21/2008 | US20080044491 Metal-containing formulations and methods of use |
| 02/21/2008 | US20080044488 Nano Glass Powder and Use Thereof, in Particular Multicomponent Glass Powder with a Mean Particle Size of Less Than 1 µm |
| 02/21/2008 | US20080044479 Antimicrobial sanitizing formulations with skin protection properties |
| 02/21/2008 | US20080044466 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| 02/21/2008 | US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| 02/21/2008 | US20080044433 Epitopes of hepatitis C virus |
| 02/21/2008 | US20080044413 EphA2 BiTE molecules and uses thereof |
| 02/21/2008 | US20080044402 Use of fermented wheat-germ in the feeding and veterinary practice |
| 02/21/2008 | US20080044400 Targeted enzyme prodrug therapy |
| 02/21/2008 | US20080044394 Methods for genetic modification of hematopietic progenitor cells and uses of the modified cells |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044391 Different dendritic cell subsets |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/21/2008 | US20080044377 Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine |
| 02/21/2008 | DE202007015417U1 Präparat zur Bekämpfung von Herpes labialis, Herpes vaginalis, Psoriasis, Schmerzen von Verbrennungen 1.ten und 2.ten Grades, infizierten Hautpartien und Neurodermitis 1.ten preparation to combat herpes labialis, herpes vaginalis, psoriasis, pain from burns and 2.ten degree, infected skin and eczema |
| 02/21/2008 | DE102006039148A1 Verwendung von Chloro- und Fluoromethylketon-Derivaten in der anti-viralen Therapie Using chloroform and Fluoromethylketon derivatives in the anti-viral therapy |
| 02/21/2008 | DE102006038403A1 Verwendung bestimmter chemischer Verbindungen zur Inhibierung der Peptidyl-Prolyl-cis/trans-Isomeraseaktivität von Cyclophilinen The use of certain chemical compounds for inhibition of the peptidyl-prolyl cis / trans isomerase activity of cyclophilins |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/21/2008 | CA2660628A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/21/2008 | CA2660520A1 Hepatitis c virus inhibitors |
| 02/21/2008 | CA2658984A1 Non-nucleoside reverse transcriptase inhibitors |